Leslie Norman
Women's Health · Germantown, TNNPI 1215234505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations.
Across 75 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$277
- Novo Nordisk$255
- Myriad Genetic Laboratories, Inc.$180
- Shield Therapeutics Inc$160
- Amgen$160
- Gilead$144
- plus $876 from 20 others
What the payments were for
- Food & beverage$1,95195%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $277 |
| Novo Nordisk | 3 | $255 |
| Myriad Genetic Laboratories, Inc. | 4 | $180 |
| Shield Therapeutics Inc | 10 | $160 |
| Amgen | 4 | $160 |
| Gilead | 2 | $144 |
| Medtronic | 4 | $121 |
| Daiichi Sankyo Inc. | 4 | $89 |
| AbbVie | 4 | $82 |
| Exeltis, USA Inc. | 4 | $70 |
| Mayne Pharma Commercial LLC | 4 | $59 |
| AstraZeneca | 3 | $54 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Merck | 3 | $48 |
| Myovant Sciences Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $44 |
| Bayer | 2 | $34 |
| Scynexis, Inc. | 2 | $32 |
| Pfizer | 2 | $32 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Coopersurgical, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,051 in reported general payments places this provider in the 80th percentile of 202 women's health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $954 |
| Ondansetron OdtOndansetron | 21 | $66 |
| Oxycodone Hcl | 23 | $28 |
Paid to pharmacies, not to this prescriber.
Other women's health in Germantown
- Virginia McGheeGermantown$5K
- Kendall SacharczykGermantown$2K
- Haley WoodFranklin$92K
- Dana DemossNashville$76K
- Royanne MooreNashville$29K
- Laurie TompkinsBrentwood$27K
- Lana HirschNashville$24K
- Yoshie DarnallNashville$10K
- Lisa GoehringNashville$9K
- Anya ZerillaKnoxville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.